1. Home
  2. NTGR vs AKBA Comparison

NTGR vs AKBA Comparison

Compare NTGR & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTGR
  • AKBA
  • Stock Information
  • Founded
  • NTGR 1996
  • AKBA 2007
  • Country
  • NTGR United States
  • AKBA United States
  • Employees
  • NTGR N/A
  • AKBA N/A
  • Industry
  • NTGR Telecommunications Equipment
  • AKBA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTGR Utilities
  • AKBA Health Care
  • Exchange
  • NTGR Nasdaq
  • AKBA Nasdaq
  • Market Cap
  • NTGR 820.0M
  • AKBA 958.6M
  • IPO Year
  • NTGR N/A
  • AKBA 2014
  • Fundamental
  • Price
  • NTGR $25.14
  • AKBA $3.42
  • Analyst Decision
  • NTGR Buy
  • AKBA Strong Buy
  • Analyst Count
  • NTGR 1
  • AKBA 5
  • Target Price
  • NTGR $29.00
  • AKBA $6.90
  • AVG Volume (30 Days)
  • NTGR 562.2K
  • AKBA 3.8M
  • Earning Date
  • NTGR 07-30-2025
  • AKBA 08-07-2025
  • Dividend Yield
  • NTGR N/A
  • AKBA N/A
  • EPS Growth
  • NTGR N/A
  • AKBA N/A
  • EPS
  • NTGR 2.16
  • AKBA N/A
  • Revenue
  • NTGR $697,865,000.00
  • AKBA $203,733,000.00
  • Revenue This Year
  • NTGR $4.48
  • AKBA $27.95
  • Revenue Next Year
  • NTGR $5.04
  • AKBA $43.88
  • P/E Ratio
  • NTGR $11.62
  • AKBA N/A
  • Revenue Growth
  • NTGR 0.41
  • AKBA 16.75
  • 52 Week Low
  • NTGR $14.86
  • AKBA $1.07
  • 52 Week High
  • NTGR $31.55
  • AKBA $4.08
  • Technical
  • Relative Strength Index (RSI)
  • NTGR 42.98
  • AKBA 44.17
  • Support Level
  • NTGR $21.59
  • AKBA $2.92
  • Resistance Level
  • NTGR $26.10
  • AKBA $3.79
  • Average True Range (ATR)
  • NTGR 1.11
  • AKBA 0.20
  • MACD
  • NTGR -0.00
  • AKBA -0.06
  • Stochastic Oscillator
  • NTGR 57.26
  • AKBA 44.64

About NTGR NETGEAR Inc.

Netgear Inc provider of networking technologies for businesses, homes, and service providers. It delivers a wide range of intelligent solutions designed to unleash the full potential of connectivity. The group has two segments: NETGEAR for Business and Connected Home which offers reliable, easy-to-use, high-performance networking solutions, including switches, routers, access points, software, and AV over IP technologies, tailored to meet the diverse needs of organizations of all sizes. The Connected Home segment offers connectivity, powerful performance, and enhanced security features right out of the box, designed to help keep families safe online, and Others. It conduct business across three geographic territories: Americas; Europe, Middle East and Africa; and Asia Pacific.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: